DE:6XB3 Stock Latest News
Company AnnouncementsBiophytis Secures €1 Million Bond Financing to Boost Clinical Development1y ago
Company AnnouncementsBiophytis Completes €2.6 Million Private Placement1y ago
Company AnnouncementsBiophytis Raises €2.6 Million to Boost Clinical Programs1y ago
Company AnnouncementsBiophytis Unveils Promising Preclinical Data for Obesity Treatment1y ago
Company AnnouncementsBiophytis Advances in Sarcopenia Treatment with Promising Phase II Results1y ago
Company AnnouncementsBiophytis to Participate in BIO-Europe Spring Conference to Discuss Drug Development1y ago- Company AnnouncementsBiophytis Partners with AskHelpU to Advance ALS Treatment in China1y ago
Company AnnouncementsBiophytis Pursues Strategic Partnership in China for BIO1011y ago
Company AnnouncementsBiophytis Secures €8.6 Million for Obesity Program Development1y ago
Company AnnouncementsBiophytis Temporarily Suspends Share Listing for Refinancing1y ago
Company AnnouncementsBiophytis SA Advances Obesity Treatment with BIO1011y ago
Company AnnouncementsBiophytis SA Advances Obesity Study with FDA Nod2y ago
Company AnnouncementsBiophytis Announces Promising COVID-19 Study Results2y ago- Company AnnouncementsBiophytis SA Achieves Full Resolution Approval2y ago
- Company AnnouncementsBiophytis Secures Lucrative Deal for BIO101 in Latin America2y ago
Company AnnouncementsBiophytis Secures Extended Bond Financing Deal2y ago